Home / Stocks / AUPH

AUPH insider trading

Aurinia Pharmaceuticals Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
5
Bought · 24 mo
$62.3M
Buys · last 90 days
0 · $0
Most recent buy
2026-06-02

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-06-02TANG KEVIN
Chief Executive Officer
Bought814,606$15.29$12.5M
2026-03-03TANG KEVIN
Director
Bought900,000$14.10$12.7M
2025-08-05TANG KEVIN
Director
Bought1,300,000$10.45$13.6M
2025-03-04TANG KEVIN
Director
Bought1,600,000$7.95$12.7M
2025-03-04Greenleaf Peter
Chief Executive Officer
Sold360,540$7.96$2.9M
2024-12-09TANG KEVIN
Director
Bought1,200,000$9.02$10.8M

Most active insider buyers

InsiderRoleBuysTotal bought
TANG KEVINChief Executive Officer5$62.3M

See AUPH on the chart

Every insider buy and sell for AUPH plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.